InMed Pharmaceuticals Inc INM

Healthcare Cannabis

InMed Pharmaceuticals Inc. is a pharmaceutical company. It develops a pipeline of small molecule drug candidates targeting the CB1/CB2 receptors. Its InMed Pharmaceuticals segment is engaged in the research and development of small molecule pharmaceuticals drug candidates. Its BayMedica Commercial segment is engaged in the manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its pharmaceutical pipeline consists of three programs, with drug candidates targeting Alzheimer’s disease, dry age-related macular degeneration, and Epidermolysis Bullosa. Its INM-901 is a drug candidate being developed as a potential treatment for Alzheimer’s disease. Its INM-089 is cannabinoid analog being studied for its potential as a treatment for age-related macular degeneration. Its INM-755 is a cannabinol topical cream which has completed Phase 2 clinical trial studies for the treatment of epidermolysis bullosa.

NDAQ:INM - Post by User

InMed Pharmaceuticals Inc

Bullboard Posts

Comment by NYfootballeron Oct 20, 2015 2:22pm

77 Views

Post# 24209667

RE:RE:RE:RE:RE:RE:RE:RE:RE:The sellers are building up

Perfect so your an investor in gold stocks ! You're the one, i feel sorry for! Should have sticked to the porn .. might have saved you a dollar or two ! Ha So that being said gloryhole... I don't need your advice but thanks.. An old beaten up miner who thinks he knows anything about bio other then maybe taking a few tylenol to console his years of losses in mining stocks .. Oh and yes .... never said inmed was gone bit then again.. I speaking above your pay grade old timer :)

Bullboard Posts

Dollar Tree CEO Rick Dreiling steps down as discount retailer struggles